ArticleToxins2026
The Influence of Non-Starch Polysaccharide Enzymes in Diets Contaminated with Deoxynivalenol and Its Modified Form, Deoxynivalenol-3-Glucoside, on Growth Performance and Toxicokinetics in Broiler Chickens.
Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The interaction between modified forms of deoxynivalenol (DON), such as DON-3-glucoside (DON-3G), and feed enzymes is underestimated. We assessed the interaction between DON and non-starch polysaccharide enzymes (NSPases) on growth performance, and excreta levels of DON and its metabolites (Experiment 1), as well as DON toxicokinetics (Experiment 2). Broiler chickens were fed maize-based diets naturally contaminated with low (LD; 516-792 μg DON/kg diet) or moderate (MD; 2395-3020 μg DON/kg diet) levels of DON. The LD and MD diets were supplemented with or without an NSPase blend. The MD diet impaired growth performance in broiler chickens up to 14 days of age, whereas no differences were observed in older birds. NSPase supplementation decreased body weight gain (BWG) in 28-day-old broiler chickens fed the MD diet and increased excreta levels of DON-3-sulfate (DON-3S). NSPase supplementation also improved the feed conversion ratio (FCR) without increasing BWG. Additionally, NSPase altered the toxicokinetic profile of DON in broiler chickens fed the MD diet, and the time to maximum plasma concentration (T
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.